nach oben

Abdominal Radiology

Erschienen in:

02.03.2016 | Pictorial Essay

Interventional oncology: pictorial review of post-ablation imaging of liver and renal tumors

verfasst von: Stephen R. Lee, Aoife Kilcoyne, Avinash Kambadakone, Ronald Arellano

Erschienen in: Abdominal Radiology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Percutaneous image-guided ablation is now commonly performed in many institutions for the treatment of hepatocellular carcinoma, liver metastases, and renal cell carcinoma in select patients. Accurate interpretation of post-ablation imaging is of supreme importance because treatment algorithms for these diseases rely heavily on imaging to guide management decisions. The purpose of this pictorial essay is to provide abdominal imagers with a review of the indications for percutaneous ablation in the abdomen, a basic overview of ablation modalities in clinical use today, the expected post-ablation imaging findings in the liver and kidney, and potential complications of hepatic and renal ablation procedures.

Jemal A, Bray F, Ferlay J (1999) Global cancer statistics: 2011. CA Cancer J Clin 49(2):33–64. doi:10.3322/caac.20107.Available

Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485–1491. doi:10.1200/JCO.2008.20.7753 CrossRefPubMedPubMedCentral

Yang JD, Harmsen WS, Slettedahl SW, et al. (2011) Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9(7):617–623. doi:10.1016/j.cgh.2011.03.027 CrossRefPubMed

El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118–1127. doi:10.1056/NEJMra1001683 CrossRefPubMed

Livraghi T, Meloni F, Di Stasi M, et al. (2007) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47(1):82–89. doi:10.1002/hep.21933 CrossRef

Kopetz S, Chang GJ, Overman MJ, et al. (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27(22):3677–3683. doi:10.1200/JCO.2008.20.5278 CrossRefPubMedPubMedCentral

Mavros MN, de Jong M, Dogeas E, Hyder O, Pawlik TM (2013) Impact of complications on long-term survival after resection of colorectal liver metastases. Br J Surg 100(5):711–718. doi:10.1002/bjs.9060 CrossRefPubMed

Tanaka K, Adam R, Shimada H, et al. (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90(8):963–969. doi:10.1002/bjs.4160 CrossRefPubMed

Sanoff HK, McLeod HL (2008) Predictive factors for response and toxicity in chemotherapy: pharmacogenomics. Semin Colon Rectal Surg 19(4):226–230. doi:10.1053/j.scrs.2008.09.007 CrossRefPubMedPubMedCentral

10.

Kim KH, Yoon YS, Yu CS, et al. (2011) Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc 81(1):25–34. doi:10.4174/jkss.2011.81.1.25 CrossRefPubMedPubMedCentral

11.

Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RCG (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13(3):486–491. doi:10.1007/s11605-008-0727-0 CrossRefPubMed

12.

Hur H, Ko YT, Min BS, et al. (2009) Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 197(6):728–736. doi:10.1016/j.amjsurg.2008.04.013 CrossRefPubMed

13.

American Cancer Society: Cancer Facts and Figures 2015. (2015). doi:10.3322/caac.21254

14.

Campbell SC, Novick AC, Belldegrun A, et al. (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279. doi:10.1016/j.juro.2009.07.004 CrossRefPubMed

15.

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 185(1):64–71CrossRef

16.

Vogl TJ, Farshid P, Naguib NNN, et al. (2015) Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging 40:1829–1837. doi:10.1007/s00261-015-0355-6 CrossRefPubMed

17.

Simo KA, Sereika SE, Newton KN, Gerber DA (2011) Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncol 104(7):822–829. doi:10.1002/jso.21933 CrossRefPubMed

18.

Finelli A, Rewcastle JC, Jewett MAS (2003) Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies. Curr Opin Urol 13(3):187–191. doi:10.1097/01.mou.0000068743.82465.25 CrossRefPubMed

19.

Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26(4):345–360. doi:10.1007/s002610000194 CrossRefPubMed

20.

Yang D, Converse MC, Mahvi DM, Webster JG (2007) Measurement and analysis of tissue temperature during microwave liver ablation. IEEE Trans Biomed Eng 54(1):150–155. doi:10.1109/TBME.2006.884647 CrossRefPubMed

21.

Goldberg SN, Hahn PF, Tanabe KK et al. (1998). Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 9(1 Pt 1):101–11. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9468403

22.

Lu DSK, Raman SS, Limanond P, et al. (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14(10):1267–1274. doi:10.1097/01.RVI.0000092666.72261.6B CrossRefPubMed

23.

Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60(2):40–49. doi:10.1016/S0090-4295(02)01683-7 CrossRefPubMed

24.

Bagia JS, Perera DS, Morris DL (1998) Renal impairment in hepatic cryotherapy. Cryobiology 36(4):263–267. doi:10.1006/cryo.1998.2085 CrossRefPubMed

25.

Seifert JK, France MP, Zhao J, et al. (2002) Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 26(11):1333–1341. doi:10.1007/s00268-002-6139-5 CrossRefPubMed

26.

Dunne RM, Shyn PB, Sung JC, et al. (2014) Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol 83(4):632–638. doi:10.1016/j.ejrad.2014.01.007 CrossRefPubMed

27.

Wells SA, Hinshaw JL, Lubner MG, et al. (2015) Liver ablation. Radiol Clin North Am 53(5):933–971. doi:10.1016/j.rcl.2015.05.012 CrossRefPubMed

28.

Sohn RL, Carlin AM, Steffes C et al. (2003). The extent of cryosurgery increases the complication rate after hepatic cryoablation. Am Surg, 69(4):317–22; discussion 322–3. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12716090

29.

Jansen MC, van Wanrooy S, van Hillegersberg R, et al. (2008) Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors. Eur J Surg Oncol 34(6):662–667. doi:10.1016/j.ejso.2007.06.009 CrossRefPubMed

30.

Lee EW, Wong D, Prikhodko SV, et al. (2012) Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol 23(1):107–113. doi:10.1016/j.jvir.2011.09.020 CrossRefPubMed

31.

Ben-David E, Appelbaum L, Sosna J, Nissenbaum I, Goldberg SN (2012) Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol 198(1):W62–W68. doi:10.2214/AJR.11.6940 CrossRefPubMed

32.

Lee EW, Chen C, Prieto VE, et al. (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433. doi:10.1148/radiol.10090337 CrossRefPubMed

33.

Thomson KR, Cheung W, Ellis SJ, et al. (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621. doi:10.1016/j.jvir.2010.12.014 CrossRefPubMed

34.

Cannon R, Ellis S, Hayes D, Narayanan G, Martin RCG (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107(5):544–549. doi:10.1002/jso.23280 CrossRefPubMed

35.

Lu DSK, Kee ST, Lee EW (2013) Irreversible electroporation: ready for prime time? Tech Vasc Interv Radiol 16(4):277–286. doi:10.1053/j.tvir.2013.08.010 CrossRefPubMed

36.

Burrel M, Llovet JM, Ayuso C, et al. (2003) MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38(4):1034–1042. doi:10.1053/jhep.2003.50409 CrossRefPubMed

37.

Vogl TJ, Kummel S, Hammerstingl R, et al. (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200(1):59–67. doi:10.1148/radiology.200.1.8657946 CrossRefPubMed

38.

Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31(6):1547–1568. doi:10.1148/rg.316115528 CrossRefPubMed

39.

Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. Am J Roentgenol 195(1):13–28. doi:10.2214/AJR.10.4392 CrossRef

40.

Ahn SS, Kim M-J, Lim JS, et al. (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255(2):459–466. doi:10.1148/radiol.10091388 CrossRefPubMed

41.

Lee DH, Lee JM, Baek JH, et al. (2015) Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Radiology 274(1):149–160. doi:10.1148/radiol.14140141 CrossRefPubMed

42.

Kim YK, Park G, Kim CS, Yu HC, Han YM (2012) Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT. Br J Radiol 85(May):539–547. doi:10.1259/bjr/25139667 CrossRefPubMedPubMedCentral

43.

Kim HJ, Lee SS, Byun JH, et al. (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274(3):712–722. doi:10.1148/radiol.14140390 CrossRefPubMed

44.

Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188(2):480–488. doi:10.2214/AJR.05.2079 CrossRefPubMed

45.

Forner A, Ayuso C, Varela M, et al. (2009) Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115:616–623. doi:10.1002/cncr.24050 CrossRefPubMed

46.

Dromain C, de Baere T, Elias D, et al. (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262. doi:10.1148/radiol.2231010780 CrossRefPubMed

47.

Ahmed M, Solbiati L, Brace CL, et al. (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology 273(1):241–260. doi:10.1148/radiol.14132958 CrossRefPubMedPubMedCentral

48.

Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H (2003) FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28(3):192–197. doi:10.1097/01.RLU.0000053530.95952.FD PubMed

49.

Vogt FM, Antoch G, Veit P, et al. (2007) Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT. J Nucl Med 48(11):1836–1844. doi:10.2967/jnumed.107.042846 CrossRefPubMed

50.

McLoney E, Isaacson A, Keating P (2014) The role of PET imaging before, during, and after percutaneous hepatic and pulmonary tumor ablation. Semin Interv Radiol 31(02):187–192. doi:10.1055/s-0034-1373793 CrossRef

51.

Nielsen K, van Tilborg AAJM, Scheffer HJ, et al. (2013) PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Eur J Radiol 82(12):2169–2175. doi:10.1016/j.ejrad.2013.08.024 CrossRefPubMed

52.

Sainani NI, Gervais DA, Mueller PR, Arellano RS (2013) Imaging after percutaneous radiofrequency ablation of hepatic tumors: part 2, abnormal findings. Am J Roentgenol 200(1):194–204. doi:10.2214/AJR.12.8479 CrossRef

53.

Kim SH, Lim HK, Choi D, et al. (2004) Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol 183(6):1611–1617. doi:10.2214/ajr.183.6.01831611 CrossRefPubMed

54.

Shankar S, vanSonnenberg E, Silverman SG, Tuncali K, & Morrison PR (2003). Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases. AJR Am J Roentgenol, 181(2):475–477. Retrieved from http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med4&NEWS=N&AN=12876029

55.

Choi D, Lim HK, Kim MJ, et al. (2005) Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol 184(6):1860–1867CrossRefPubMed

56.

Venkatesan AM, Wood BJ, Gervais DA (2011) Percutaneous ablation in the kidney. Radiology 261(2):375–391. doi:10.1148/radiol.11091207 CrossRefPubMedPubMedCentral

57.

Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG (2008) Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 19(9):1311–1320. doi:10.1016/j.jvir.2008.05.014 CrossRefPubMed

58.

Rhim H, Dodd GD, Chintapalli KN, et al. (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24(1):41–52. doi:10.1148/rg.241025144 CrossRefPubMed

59.

Maybody M, Solomon SB (2007) Image-guided percutaneous cryoablation of renal tumors. Tech Vasc Interv Radiol 10:140–148. doi:10.1053/j.tvir.2007.09.009 CrossRefPubMed

60.

Permpongkosol S, Nicol TL, Bagga HS, et al. (2006) Prophylactic gelatin sponge tract injection to prevent bleeding after percutaneous renal cryoablation in a swine model. J Vasc Interv Radiol JVIR 17(9):1505–1509. doi:10.1097/01.RVI.0000235773.23394.51 CrossRefPubMed

61.

Park BK, Kim CK, Moo HL (2007) Arteriovenous fistula after radiofrequency ablation of a renal tumor located within the renal sinus. J Vasc Interv Radiol JVIR 18(9):1183–1185. doi:10.1016/j.jvir.2007.06.015 CrossRefPubMed

62.

Howenstein MJ, Sato KT (2010) Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Interv Radiol 27(3):285–295. doi:10.1055/s-0030-1261787 CrossRef

63.

Breen DJ, Rutherford EE, Stedman B, et al. (2007) Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Interv Radiol 30(5):936–942. doi:10.1007/s00270-007-9090-x CrossRef

64.

El Dib R, Touma NJ, Kapoor A (2009) Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J 3(2):143–149

65.

Cantwell CP, Wah TM, Gervais DA, et al. (2008) Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol JVIR 19(7):1034–1040. doi:10.1016/j.jvir.2008.04.005 CrossRefPubMed

66.

Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL (2014) Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation—what should you use and why? Radiographics 34(5):1344–1362. doi:10.1148/rg.345140054 CrossRefPubMedPubMedCentral

67.

Boss A, Clasen S, Kuczyk M, et al. (2005) Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. AJR Am J Roentgenol 185(6):1627–1631. doi:10.2214/AJR.04.1946 CrossRefPubMed

68.

Lee SJ, Choyke LT, Locklin JK, Wood BJ (2006) Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J Vasc Interv Radiol JVIR 17(12):1967–1969. doi:10.1097/01.RVI.0000248829.49442.0E CrossRefPubMed

69.

Chopra S, Dodd GD III, Chanin MP, Chintapalli KN (2003) Radiofrequency ablation of hepatic tumors adjacent to the gallblader: feasibility and safety. AJR Am J Roentgenol 180:697–701CrossRefPubMed

70.

Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR (2005) Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. Am J Roentgenol 185(1):72–80. doi:10.2214/ajr.185.1.01850072 CrossRef

71.

Patel SR, Hinshaw JL, Lubner MG, et al. (2012) Hydrodissection using an iodinated contrast medium during percutaneous renal cryoablation. J Endourol 26(5):463–466. doi:10.1089/end.2011.0516 CrossRefPubMed

72.

Atwell TD, Carter RE, Schmit GD, et al. (2012) Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol JVIR 23(1):48–54. doi:10.1016/j.jvir.2011.09.008 CrossRefPubMed

73.

Park BK, Kim CK (2009) Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol 19(9):2180–2190. doi:10.1007/s00330-009-1399-1 CrossRefPubMed

74.

Kurup AN (2014) Percutaneous ablation for small renal masses-complications. Semin Interv Radiol 31((0739–9529(Print))):42–49

75.

Zagoria RJ, Traver MA, Werle DM, et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol 189(2):429–436. doi:10.2214/AJR.07.2258 CrossRef

76.

Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES (2006) Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 240(1):6–22. doi:10.1148/radiol.2401050061 CrossRefPubMed

77.

Lokken RP, Gervais DA, Arellano RS, et al. (2007) Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol 189(4):845–848. doi:10.2214/AJR.07.2015 CrossRefPubMed

78.

Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245–1255. doi:10.1016/S0140-6736(11)61347-0 CrossRefPubMed

Titel: Interventional oncology: pictorial review of post-ablation imaging of liver and renal tumors
verfasst von: Stephen R. Lee
Aoife Kilcoyne
Avinash Kambadakone
Ronald Arellano
Publikationsdatum: 02.03.2016
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 4/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-016-0665-3

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Interventional oncology: pictorial review of post-ablation imaging of liver and renal tumors

Abstract

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Image-guided intervention in the coagulopathic patient

Difficult biopsy and drainage: just say yes

Microwave ablation of liver tumors: degree of tissue contraction as compared to RF ablation

Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series

Percutaneous image-guided cryoablation of small renal masses

Microwave ablation for liver tumors

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Radiologie